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Abstract 
Decyl-ubiquinone and decyl-plastoquinone were used as model compounds to test the potential effect of quinone derivatives on two enzymes of 
the vitamin K cycle in vitro. Substantial inhibition of y-glutamate carboxylase was found, whereas vitamin K-epoxide reductase was inhibited to 
a much lesser extent. The inhibitory effect of both decylquinones was eliminated in a time-dependent way by solubilized microsomes, but not by 
purified carboxylase. Since a wide variety of prenylquinones occur as micronutrients, these results are of potential relevance for the effects of natural 
quinones in the human diet. 
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1. Introduction 
Prenylquinones and prenylquinols like phylloquinone 
(vitamin K,), plastoquinone-9 (PQ-9), ubiquinone-10 
(UQ-lo), and ol-tocopherol (vitamin E) are produced by 
green plants where they are localized in cellular organs 
(Fig. 1). UQ-10 is a genuine constituent of the mitochon- 
dria whereas all the others occur in the thylakoid mem- 
brane, the photochemically active biomembrane of chlo- 
roplasts. Phylloquinone is a component of the photosyn- 
thetic electron transport within photosystem I [1,2], 
whereas PQ-9 and its corresponding quinol form a lipo- 
philic redox system [3]. a-Tocoquinone and cl-tocopherol 
represent another lipophilic redox system of the photo- 
chemically active thylakoids. The localization and func- 
tion of these various compounds in the plant cell have 
been reviewed recently [4]. 
In man prenylquinones are part of the daily nutriture, 
and several members of this group are regarded as mi- 
cronutrients. For instance vitamin K is an indispensable 
cofactor for the mammalian enzyme y-glutamate car- 
boxylase [5], a posttranslational enzyme which converts 
glutamate residues into y-carboxyglutamate (Gla). Be- 
sides phylloquinone, also a number of bacterial mena- 
quinones (generally known by their group-name vita- 
min K7) have ‘vitamin K activity’. The active cofactor for 
the carboxylase enzyme is vitamin K quinol (KH,), 
which is oxidized into an epoxide (KO) during the car- 
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boxylation reaction. In two successive steps KO may 
subsequently be reduced via the quinone into KH,, so 
that it may be re-used several thousand fold. The physi- 
ological cofactor for the reductase(s) involved in the re- 
cycling of vitamin K is still unknown, for in vitro systems 
dithiols (dithiothreitol, thioredoxin) have proven to be 
efficient [6]. 
Except for vitamin E, which is a weak inhibitor of 
carboxylase [7], no information is available concerning 
the in vivo or in vitro interaction of prenylquinones with 
the vitamin K-dependent carboxylase is available at this 
time. Here we demonstrate that the synthetic derivatives 
decyl-plastoquinone (d-PQ) and decyl-ubiquinone (d- 
UQ) may significantly affect the bovine liver vitamin 
K-dependent carboxylase. It is suggested that also natu- 
ral (dietary) prenylquinones should be evaluated for 
their possible effects on human vitamin K status. 
2. Materials and methods 
2. I. Materials 
Phylloquinone (vitamin K,), menaquinone-4 (MK-4) Triton X-100, 
dithiothreitol (DTT), 3-((cholamidopropyl)-dimethylammonio)-l-pro- 
pane sulphonate (CHAPS), d-PQ, d-UQ, and r-a-phosphatidyl choline 
from egg yolk were from Sigma (St. Louis, MO). Before use d-PQ and 
d-UQ were purified further by high performance liquid chromatogra- 
phy using a reversed phase column (Chrompack, Lichrosorb RP-18) 
and isocratic elution with 70% (v/v) methanol in H,O as an eluent. The 
various quinones were converted to the corresponding quinols by incu- 
bating 6 mM of quinone in the presence of 150 mM DTT at pH 8.5 and 
37°C overnight in a light-protected tube. KO was prepared according 
to the method of Tishler et al. [8]. The pentapeptide Phe-Leu-Glu-Glu- 
Leu (FLEEL) was purchased from Vega Biochemical Co. (Tucson, 
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AZ), NaH“‘C0, (56 Cilmol) and Formula 989 from New England 
Nuclear (Dreieich, Germany). Salt washed microsomes were prepared 
from normal bovine liver according to earlier described methods [9], 
and were used as starting material for the purification of carboxylase 
according to the method of Wu et al. [IO]. All chemicals were of analyt- 
ical grade or better. 
2.2. Curboxylase assay 
Standard reaction mixtures (0. I25 ml) contained: 1 mg of microsomal 
proteins, 0.4% (w/v) CHAPS, 0.5 M NaCI, 2.5 mM Tris-HCI (pH 7.5), 
4 mM FLEEL, I M (NH,),SO,, 1.5 DCi NaH14C0,, 4 mM DTT, and 
200 PM of either vitamin K, KO or KH,. Inhibitors were added as 
indicated. For tests with purified carboxylase 2 fig of enzyme was 
incubated in 0.125 ml reaction mixtures containing 0.1% (w/v) 
phosphatidyl choline, 0.1% (w/v) CHAPS, 0.15 M NaCl, 50 mM Tris- 
HCI (pH 7.5), 4 mM FLEEL, 1.5 PCi NaH14C0, and 200 PM of 
vitamin KH,. Standard incubations were performed for I5 min at 20°C 
for washed microsomes and 30 min at 20°C for purified carboxylase. 
The reactions were stopped as detailed earlier [l 11. All data are pre- 
sented as the means of three independent experiments. 
phylloquinone menaquinone - 4 
H H 
n n 
2.3. KO-reductase assay 
Standard reaction mixtures (0.25 ml) contained 2 mg of microsomal 
proteins, other components were as described for the carboxylase assay 
except for FLEEL and NaH14C0,, which were omitted. Extraction and 
analysis of the samples were performed according to Thijssen [12]. 
plastoquinone - n ubiquinone - n 
Fig. I. Structure formulas of common prenylquinones. For natural 
plastoquinones and ubiquinones n represents the number of isoprene 
residues, which may vary depending on their origin. In the synthetic 
model compounds used in this paper, the 3-position of the quinones is 
occupied by an unbranched saturated decyl chain. 
2.4. Analytical method~y 
Protein concentrations were determined according to the procedure 
described by Sedmak and Grossberg [l3]. 
3. Results 
as well as in their quinone form. The inhibition as meas- 
ured in the carboxylase assay (Table 1, 2nd lane) was 
more pronounced than that in the KO-reductase assay 
(Table 1, 3rd lane). Since carboxylase and KO-reductase 
are two distinct enzymes with different functions in the 
vitamin K cycle, these data indicate that carboxylase is 
the prime target enzyme for both inhibitors. 
In this paper vitamin K activity is defined as the ability In a second set of experiments we have tried to esti- 
of a compound to function as a cofactor in the CO,- mate the inhibitor concentration required for half-maxi- 
fixation in an in vitro model system containing bovine mal inhibition. Incubations were performed under stand- 
liver microsomes, the pentapeptide FLEEL, and ard conditions and varying inhibitor concentrations 
NaH14C0,. In this system we have tested the vitamin K using 200 ,uM of either phylloquinone or menaquinone- 
activity of d-UQ and d-PQ both in their quinone and 4. A typical example of the inhibition curves thus ob- 
their quinol form. The data are given in Table 1 and tained is given in Fig. 2, where we have represented the 
demonstrate that neither of these compounds had vita- inhibition of various forms of phylloquinone by d-UQ. 
min K activity. Vitamin K inhibitory was tested in a It is noteworthy that the extent of inhibition was inde- 
similar system, to which 0.2 mM K, quinone had been pendent of the reduction state of the vitamin, which indi- 
added. In this way we found substantial vitamin K, an- cates that among the enzymes of the vitamin K cycle, 
tagonistic activity of both d-UQ and d-PQ in their quinol y-glutamylcarboxylase isthe one most strongly inhibited 
Table 1 
Effects of prenylquinones on the enzymes of the vitamin K cycle 
Compound added Concentration (mM) Cofactor activity for: 
carboxylase (pmol 
CO, min-‘) 
Vitamin K-antagonistic activity for: 
carboxylase (% inhibition) 
(% inhibition) 
K,H, 0.2 100 n.d. n.d. 
K, 0.2 68 0 n.d. 
KO 0.2 52 n.d. 0 
d-PQ I 0 16 II 
d-PQHZ I 0 78 n.d. 
d-UQ 1 0 80 10 
d-UQH, 1 0 81 n.d. 
The cofactor activity for y-glutamylcarboxylase was measured in the crude microsomal system and is expressed as pmol CO, incorporated 
per minute. Vitamin K-antagonistic activity was tested: (a) in a carboxylating system containing a fixed amount of vitamin K, quinone (0.2 
mM), and (b) in the KO-reductase system; the data are expressed as the percentage to which both systems are inhibited. All data are the means 
of triplicate experiments. n.d. = not determined. 
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final inhibitor concentration (FM) 
Fig. 2. Inhibition of the vitamin K-dependent carboxylation by d-UQ. 
The reaction was performed with salt-washed microsomes, and was 
started with 0.2 mM of either vitamin K,H, (o), vitamin K quinone (0) 
or vitamin KO (x). 100% residual vitamin K activity stands for 15 (for 
KHz), 10.5 (for K), and 7.5 (for KO) pmol CO2 fixed per mitt, respec- 
tively. 
by d-UQ and d-PQ. This is consistent with the data 
obtained in Table 1, where - in a direct test - at similar 
concentrations of d-UQ and d-PQ the inhibition of KO- 
reductase (lane 3) was 7-8 times less than that of carbox- 
ylase (lane 2); 10-50 times higher inhibitor concentra- 
tions were required for blocking KO-reductase to the 
same extent as carboxylase (data not shown). In Fig. 2 
half-maximal inhibition was found at about 400 ,DM of 
inhibitor; at 4-fold higher inhibitor concentration the 
carboxylase reaction was almost completely blocked. 
final inhibitor concentration @M) 
Fig. 3. d-UQ inhibition in salt-washed microsomes and purified carbox- 
ylase. Vitamin K,H, (0.2 mM) was used as a coenzyme. Results are 
presented as percentage of the non-inhibited reaction. Symbols: (0) 
salt-washed microsomes; (0) purified carboxylase. 100% residual vita- 
min K activity stands for 15 pmol CO, fixed per min in the microsomal 
system and for 1.9 pmol CO_, fixed per min by purified carboxylase. 
From these curves inhibitor concentrations required for 
50% inhibition were calculated for all combinations, and 
all were closely similar: 470 PM and 390 ,uM for d-PQ 
and d-UQ in the phylloquinone system, and 460 ,uM and 
450 ,DM for d-PQ and d-UQ in the menaquinone system, 
respectively. So it seems that both menaquinone and 
phylloquinone are antagonized by d-UQ and d-PQ, and 
that the antagonistic effects of both compounds are of 
the same order of magnitude. 
Recently a purification procedure for carboxylase has 
been described [lo]. Preparations thus obtained are de- 
void of KO-reductase activity. We have also measured 
the sensitivity of purified carboxylase for d-UQ, and the 
results are shown in Fig. 3. It turned out that in the 
purified system 50% inhibition was obtained at 5-fold (91 
vs. 430 ,DM) lower inhibitor concentrations. For d-PQ 
these figures were 85 and 426 ,uM, respectively (data not 
shown). 
Finally we have prepared a time course of the inhibited 
and the non-inhibited reactions. As is shown in Fig. 4A 
the non-purified system is inhibited by d-UQ (and by 
d-PQ, data not shown) for 10 min, after which the car- 
boxylation reaction proceeds at a normal rate. Preincu- 
bation of the inhibitor with the microsomal proteins for 
15 min prior to starting the carboxylation reaction with 
:Yiw ----” 
0 10 20 30 40 
time (min) 
Fig. 4. Time-dependent inhibition of the carboxylation by d-UQ. Vita- 
min K,H, (0.2 mM) was used as a coenzyme, and all reactions were 
performed at a fixed inhibitor concentration (1 mM). (A) Salt-washed 
microsomes. (B) Purified carboxylase. Symbols: (0) non-inhibited reac- 
tion; (0) carboxylation in the presence of inhibitor; (x) carboxylation 
after preincubation of inhibitor and microsomal proteins for 15 min at 
20°C. 
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vitamin K even completely abolished the inhibitory ef- 
fect. Apparently the inhibitor was degraded or removed 
from solution during the preincubation period. As is 
shown in Fig. 4B purified carboxylase was unable to 
neutralize the inhibitory effect of d-UQ even after incu- 
bation periods of 40 min and longer. 
4. Discussion 
A wide variety of quinone derivatives form part of the 
human diet, whereas our knowledge about the intestinal 
absorption and pharmacology of these compounds is 
still far from complete. Also it is unknown if, and to what 
extent, prenyl- and other quinones interfere with vitamin 
K-dependent reactions in liver, bone, and other tissues 
known to contain y-glutamate carboxylase. To get an 
impression about the potential vitamin K or vitamin 
K-antagonistic activity of these quinones, we have used 
bovine liver in vitro systems, in which two synthetic de- 
rivatives plastoquinone and ubiquinone were tested. 
It was found that both model compounds (decyl- 
plastoquinone and decyl-ubiquinone) behaved very simi- 
larly. Salt-washed, solubilized microsomes were used to 
compare the effects on y-glutamate carboxylase and vita- 
min KO-reductase. Both quinones turned out to be in- 
hibitors of the enzymes of the vitamin K cycle, but the 
effect on carboxylase was much stronger than that on 
KO-reductase. A problem here is that KO-reductase has 
not yet been purified, so that the experiments had to be 
performed in the rather crude microsomal system. It 
cannot be excluded, therefore, that part of the inhibitory 
activity is masked by non-specific adsorption of the 
decylquinones to contaminating proteins or phospholip- 
ids. This became clear from an experiment in which we 
compared the inhibitory activity of d-UQ in solubilized 
microsomes and purified carboxylase. It turned out that 
the purified enzyme was inhibited at least 5-fold stronger 
than the non-purified one. 
An interesting phenomenon was that in time-course 
studies in the microsomal system the inhibitory effect of 
decylquinones decreased after 10-l 5 min, whereas in the 
purified system the inhibitory activity persisted, also 
after very long incubation periods. Pre-incubation of d- 
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UQ with the solubilized microsomes even completely 
eliminated its inhibitory effect. Whether this elimination 
forms part of a biochemical degradation pathway is not 
clear at this time, but if so this pathway must be able to 
select plastoquinone and ubiquinone derivatives from 
phylloquinone and menaquinones, because the latter 
compounds are not affected under the conditions em- 
ployed. 
From the data presented in this paper we conclude 
that derivatives of plastoquinone and ubiquinone may 
form a new class of vitamin K-antagonists. It seems plau- 
sible that also natural quinones (e.g. those prominently 
found in the human diet) may possess vitamin K antag- 
onistic activity in vitro. If similar effects will be found in 
vivo, dietary quinones may interfere with vitamin K- 
mediated processes like blood coagulation and bone me- 
tabolism. 
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